The Effects of Catechol O-methyltransferase Genotype on Brain Activation Elicited by Affective Stimuli and Cognitive Tasks

Catechol-O-methyltransferase (COMT) degrades the catecholamine neurotransmitters dopamine, epinephrine, and norepinephrine. A functional polymorphism in the COMT gene (val158 met) accounts for a four-fold variation in enzyme activity. The low activity met158 allele has been associated with improved working memory, executive functioning, and attentional control, but also with a higher risk of anxiety-related behaviors. In spite of the strong effect of the COMT genotype on enzyme activity, its effects on behavior are moderate, accounting for only 4% of variance in task performance. Studies of individuals with intermediate phenotypes during activities such as task-dependent brain activation, may more sensitively detect gene effects on the brain. A series of studies using functional magnetic resonance imaging (fMRI) assessed the effects of the COMT val158 met genotype on central processing during working memory, attentional control, and emotional tasks. fMRI revealed a more focused response in the prefrontal cortex (PFC) of met158 allele carriers during a working memory task. A comparable effect during the performance of an attentional control task in the cingulate cortex was also observed. These data indicate that met158 allele load is associated with improved processing efficiency in the PFC and cingulate, which might be due to lower prefrontal dopamine (DA) metabolism, higher DA concentrations, and an increased neuronal signal-to-noise ratio during information processing. During performance of an emotional task, reactivity to unpleasant visual stimuli was positively correlated with the number of met158 alleles in the amygdala, as well as in other limbic and paralimbic nodes. This increased limbic reactivity to unpleasant stimuli might be the underlying cause of the lower emotional resilience against negative mood states observed in individuals with a higher met158 allele load. Thus the met158 allele seems to be beneficial during the performance of working memory and attention-related tasks, whereas the val158 allele appears to be advantageous during the processing of aversive emotional stimuli.

[1]  Andreas Heinz,et al.  Catechol-O-Methyltransferase val158met Genotype Affects Processing of Emotional Stimuli in the Amygdala and Prefrontal Cortex , 2005, The Journal of Neuroscience.

[2]  E. Pehek,et al.  Effects of catecholamine uptake blockers in the caudate-putamen and subregions of the medial prefrontal cortex of the rat , 2002, Brain Research.

[3]  Francesco Fera,et al.  Dextroamphetamine Modulates the Response of the Human Amygdala , 2002, Neuropsychopharmacology.

[4]  D. Shields,et al.  Preliminary evidence of an association between bipolar disorder in females and the catechol‐O‐methyltransferase gene , 1998, Psychiatric genetics.

[5]  Henry Kranzler,et al.  Serotonin transporter protein (SLC6A4) allele and haplotype frequencies and linkage disequilibria in African- and European-American and Japanese populations and in alcohol-dependent subjects , 1997, Human Genetics.

[6]  J. Gray,et al.  Anxiolytic action on the behavioural inhibition system implies multiple types of arousal contribute to anxiety. , 2000, Journal of affective disorders.

[7]  M. Koulu,et al.  Association between the functional variant of the catechol-O-methyltransferase (COMT) gene and type 1 alcoholism , 1999, Molecular Psychiatry.

[8]  R. Straub,et al.  Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[9]  Huda Akil,et al.  Neural circuits mediating stress , 1999, Biological Psychiatry.

[10]  R. Coppola,et al.  Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia. , 2003, Archives of general psychiatry.

[11]  K. Ohara,et al.  No association between anxiety disorders and catechol-O-methyltransferase polymorphism , 1998, Psychiatry Research.

[12]  R. Weinshilboum,et al.  Genetics of red cell COMT activity: analysis of thermal stability and family data. , 1981, American journal of medical genetics.

[13]  A. Grace,et al.  Modulation of Basolateral Amygdala Neuronal Firing and Afferent Drive by Dopamine Receptor Activation In Vivo , 1999, The Journal of Neuroscience.

[14]  D. Weinberger,et al.  Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. III. A new cohort and evidence for a monoaminergic mechanism. , 1988, Archives of general psychiatry.

[15]  Martin Reuter,et al.  Association of the functional catechol-O-methyltransferase VAL158MET polymorphism with the personality trait of extraversion , 2005, Neuroreport.

[16]  S. Ho,et al.  Human catechol-O-methyltransferase down-regulation by estradiol , 2003, Neuropharmacology.

[17]  N C Andreasen,et al.  Catechol-O-methyl transferase Val158Met gene polymorphism in schizophrenia: working memory, frontal lobe MRI morphology and frontal cerebral blood flow , 2005, Molecular Psychiatry.

[18]  H. Lachman,et al.  Ultra-ultra rapid cycling bipolar disorder is associated with the low activity catecholamine-O-methyltransferase allele , 1998, Molecular Psychiatry.

[19]  Murray B Stein,et al.  COMT Polymorphisms and Anxiety-Related Personality Traits , 2005, Neuropsychopharmacology.

[20]  K. Luan Phan,et al.  Functional Neuroanatomy of Emotion: A Meta-Analysis of Emotion Activation Studies in PET and fMRI , 2002, NeuroImage.

[21]  J. Coull.  Neural correlates of attention and arousal: insights from electrophysiology, functional neuroimaging and psychopharmacology , 1998, Progress in Neurobiology.

[22]  R. Wise,et al.  Dopamine Uptake through the Norepinephrine Transporter in Brain Regions with Low Levels of the Dopamine Transporter: Evidence from Knock-Out Mouse Lines , 2002, The Journal of Neuroscience.

[23]  R. Weinshilboum,et al.  Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. , 1996, Pharmacogenetics.

[24]  S. Southwick,et al.  Noradrenergic mechanisms in stress and anxiety: I. preclinical studies , 1996, Synapse.

[25]  Joshua A. Bueller,et al.  COMT val158met Genotype Affects µ-Opioid Neurotransmitter Responses to a Pain Stressor , 2003, Science.

[26]  M. Egan,et al.  Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[27]  S. Holland,et al.  fMRI of neuronal activation with symptom provocation in unmedicated patients with obsessive compulsive disorder. , 2000, Journal of psychiatric research.

[28]  A. Sampson,et al.  Dopamine transporter immunoreactivity in monkey cerebral cortex: Regional, laminar, and ultrastructural localization , 2001, The Journal of comparative neurology.

[29]  B. Mensour,et al.  Separate neural circuits for primary emotions? Brain activity during self-induced sadness and happiness in professional actors , 2003, Neuroreport.

[30]  I. Ulmanen,et al.  Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. , 1995, Biochemistry.

[31]  M. Egan,et al.  Effect of Catechol-O-Methyltransferase val158met Genotype on Attentional Control , 2005, The Journal of Neuroscience.

[32]  B. Mensour,et al.  Neural circuitry underlying voluntary suppression of sadness , 2003, Biological Psychiatry.

[33]  W. Drevets.  Neuroimaging studies of mood disorders , 2000, Biological Psychiatry.

[34]  S. Rauch,et al.  Neurobiology of emotion perception I: the neural basis of normal emotion perception , 2003, Biological Psychiatry.

[35]  M. Koulu,et al.  Association between the functional polymorphism of catechol-O-methyltransferase gene and alcohol consumption among social drinkers. , 2000, Alcoholism, clinical and experimental research.

[36]  H. Lanfermann,et al.  Engagement of Lateral and Medial Prefrontal Areas in the Ecphory of Sad and Happy Autobiographical Memories , 2003, Cortex.

[37]  M Knapp,et al.  Association study of the low-activity allele of catechol-O-methyltransferase and alcoholism using a family-based approach , 2001, Molecular Psychiatry.

[38]  P Vuilleumier,et al.  Neural response to emotional faces with and without awareness: event-related fMRI in a parietal patient with visual extinction and spatial neglect , 2002, Neuropsychologia.

[39]  M. Bradley,et al.  Emotional arousal and activation of the visual cortex: an fMRI analysis. , 1998, Psychophysiology.

[40]  Douglas W. Jones,et al.  The effect of amphetamine on regional cerebral blood flow during cognitive activation in schizophrenia , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[41]  R. Coppola,et al.  Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited. , 2000, Cerebral cortex.

[42]  D. Weinberger,et al.  Evidence of dysfunction of a prefrontal-limbic network in schizophrenia: a magnetic resonance imaging and regional cerebral blood flow study of discordant monozygotic twins. , 1992, The American journal of psychiatry.

[43]  Jurg Ott,et al.  Family-based association studies support a sexually dimorphic effect of COMT and MAOA on genetic susceptibility to obsessive-compulsive disorder , 1999, Biological Psychiatry.

[44]  R. V. Van Heertum,et al.  Prefrontal Dopamine D1 Receptors and Working Memory in Schizophrenia , 2002, The Journal of Neuroscience.

[45]  David Goldman,et al.  Genetics of alcoholism using intermediate phenotypes. , 2003, Alcoholism, clinical and experimental research.

[46]  Francesco Fera,et al.  Dopamine Modulates the Response of the Human Amygdala: A Study in Parkinson's Disease , 2002, The Journal of Neuroscience.

[47]  M. Egan,et al.  Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. , 2004, American journal of human genetics.

[48]  Steven C. R. Williams,et al.  Neural correlates of anxiety associated with obsessive-compulsive symptom dimensions in normal volunteers , 2003, Biological Psychiatry.

[49]  S. Siris,et al.  Implications of normal brain development for the pathogenesis of schizophrenia. , 1988, Archives of general psychiatry.

[50]  Kenneth K Kidd,et al.  Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles , 1999, Biological Psychiatry.

[51]  R. Weinshilboum,et al.  Methylation pharmacogenetics: catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase. , 1999, Annual review of pharmacology and toxicology.

[52]  R. Coppola,et al.  Physiological characteristics of capacity constraints in working memory as revealed by functional MRI. , 1999, Cerebral cortex.

[53]  Giuseppe Esposito,et al.  Dextroamphetamine Enhances “Neural Network-Specific” Physiological Signals: A Positron-Emission Tomography rCBF Study , 1996, The Journal of Neuroscience.

[54]  C. Benkelfat,et al.  Catechol-O-methyltransferase Val-108/158-Met gene variants associated with performance on the Wisconsin Card Sorting Test. , 2002, Archives of general psychiatry.

[55]  I. Borecki,et al.  Familial resemblance and heritability. , 2001, Advances in genetics.

[56]  K. Ohara,et al.  Low activity allele of catechol‐o‐methyltransferase gene and Japanese unipolar depression , 1998, Neuroreport.

[57]  Sung-Cheng Huang,et al.  Differential cerebral metabolic changes with paroxetine treatment of obsessive-compulsive disorder vs major depression. , 2002, Archives of general psychiatry.

[58]  A. Malhotra,et al.  A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. , 2002, The American journal of psychiatry.

[59]  D. Pfaff,et al.  Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[60]  Karl J. Friston,et al.  A neuromodulatory role for the human amygdala in processing emotional facial expressions. , 1998, Brain : a journal of neurology.

[61]  D. Weinberger,et al.  Brain imaging in schizophrenia. , 1995, Annual review of medicine.

[62]  David Goldman,et al.  Genetic origins of anxiety in women: a role for a functional catechol-O-methyltransferase polymorphism , 2003, Psychiatric genetics.

[63]  K. Lesch,et al.  Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory Region , 1996, Science.

[64]  S. Rauch,et al.  Schizophrenic subjects show aberrant fMRI activation of dorsolateral prefrontal cortex and basal ganglia during working memory performance , 2000, Biological Psychiatry.